Balyasny Asset Management
ADCT icon

Balyasny Asset Management’s ADC Therapeutics ADCT Stock Holding History

Balyasny Asset Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,765
Closed -$107K – 1878
2024
Q1 		$107K Buy
+23,765
New +$107K ﹤0.01% 1869
2022
Q3 		– Sell
-86,100
Closed -$684K – 2321
2022
Q2 		$684K Buy
+86,100
New +$684K ﹤0.01% 1493